HBIO Earnings

Quarterly EPS
$0.00
Q4 2024
$-11.42
Q1 2025
$-0.52
Q2 2025
$-0.28
Q3 2025
$-0.64
Q4 2025
$-0.77
Q1 2026
$-0.64
Q2 2026
$-0.58
Q3 2026
Latest Revenue22.2M
Latest Net Income-2623000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$0.5822.2M-2623000+7.8%-107.1%
Q2 2026-$0.6422.7M-2910000+11.1%-23.1%
Q1 2026-$0.7720.8M-3424000-4.7%+93.3%
Q4 2025-$0.6423.7M-2847000-3.3%—
Q3 2025-$0.2820.6M-1231000-6.3%+74.5%
Q2 2025-$0.5220.4M-2282000-11.5%+25.7%
Q1 2025-$11.4221.8M-50340000-11.2%-938.2%
Q4 2024$0.0024.6M18.0K-12.8%+100.0%
Q3 2024-$1.1022.0M-4802000——
Q2 2024-$0.7023.1M-2927000——
Q1 2024-$1.1024.5M-4694000——
Q4 2023-$0.4328.2M-1818000——
Harvard Bioscience (HBIO) — Earnings